Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed versus immediate oxytocin after amniotomy for induction of labour
NL-OMON45440Active, not recruiting
- Sponsor
- OLVG
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin (2 arms), sponsored by OLVG. Primary endpoints: Amniotomy to delivery interval and Patient satisfaction. Started Nov 2017; status: active, not recruiting.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NL-OMON45440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45440.